MedTrace Logo

Effect of Vitamin D as add-on Therapy for Vitamin D Insufficient Patients With Severe Asthma

NCT02424552 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2017-05-01

No results posted yet for this study

Summary

The purpose of the EVITA trial is to compare the effects of vitamin D therapy with placebo on reducing the dose of inhaled or oral corticosteroids in patients with severe asthma and vitamin D insufficiency.

Conditions

Interventions

DRUG

Vitamin D3

Initial single dose 100000 IU, beginning from the second day 4000 IU/day for 24 weeks.

DRUG

Placebo

Filling material: lactose monohydrate, cellulose, magnesium stearate

Sponsors & Collaborators

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV

  • Johannes Gutenberg University Mainz

    lead OTHER

Principal Investigators

  • Stephanie Korn, MD · Johannes Gutenberg University Mainz

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-26
Primary Completion
2017-02-09
Completion
2017-03-09

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02424552 on ClinicalTrials.gov